PKS-21004

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NamePKS-21004
Drug Alias NamePKS-21004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProteasome subunit beta type-8 inhibitors
TargetsProteasome subunit beta type-8
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Brigham and Women's HospitalWeill Cornell Medical College
China Registration ClassN/A

Develop Information

Active CompaniesThe Brigham and Women's HospitalWeill Cornell Medical College
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A